Mylan N.V. (MYL): Price and Financial Metrics


Mylan N.V. (MYL)

Today's Latest Price: $17.19 USD

1.49 (-7.98%)

Updated Feb 28 12:00am

Add MYL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MYL Stock Summary

  • With a market capitalization of $11,380,722,066, Mylan NV has a greater market value than 85.38% of US stocks.
  • Mylan NV's stock had its IPO on December 18, 1987, making it an older stock than 90.12% of US equities in our set.
  • MYL's current price/earnings ratio is 239.59, which is higher than 97.53% of US stocks with positive earnings.
  • If you're looking for stocks that are quantitatively similar to Mylan NV, a group of peers worth examining would be LOGM, ELAN, PKI, CAE, and WAT.
  • Visit MYL's SEC page to see the company's official filings. To visit the company's web site, go to www.mylan.com.
MYL Daily Price Range
MYL 52-Week Price Range

MYL Stock Price Chart More Charts


MYL Price/Volume Stats

Current price $17.19 52-week high $29.30
Prev. close $18.68 52-week low $16.57
Day low $16.57 Volume 16,177,200
Day high $18.09 Avg. volume 6,308,833
50-day MA $20.96 Dividend yield N/A
200-day MA $19.41 Market Cap 8.87B

Mylan N.V. (MYL) Company Bio


Mylan NV develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company was founded in 1961 and is based in Potters Bar, Hertfordshire.

MYL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$17.19$24.79 27%

We started the process of determining a valid price forecast for Mylan NV with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Mylan NV ranked in the 60th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 27.5% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for MYL, they are:

  • 44% of the company's capital comes from equity, which is greater than only 18.26% of stocks in our cash flow based forecasting set.
  • Relative to other stocks in its sector (Healthcare), Mylan NV has a reliance on debt greater than 88.31% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%24%
1%26%
2%27%
3%28%
4%29%
5%31%

Want more companies with a valuation profile/forecast similar to that of Mylan NV? See UNH, MEDP, AMED, MGLN, and DVA.


MYL Latest News Stream


Event/Time News Detail
Loading, please wait...

MYL Latest Social Stream


Loading social stream, please wait...

View Full MYL Social Stream

MYL Price Returns

1-mo -21.58%
3-mo -8.47%
6-mo -11.71%
1-year -37.38%
3-year -61.69%
5-year -70.31%
YTD -14.48%
2019 -26.64%
2018 -35.24%
2017 10.90%
2016 -29.44%
2015 -4.08%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6466 seconds.